APPLICATION
ANDA203051
TYPE
ANDA
ORIGINAL APPROVAL
2018-10-09
LATEST ACTION
2022-11-23
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
BIMATOPROSTDiscontinued
BIMATOPROST 0.03% · SOLUTION/DROPS · TOPICAL
Approval history
2022-11-23Labeling · Supplement 5 · standardAP
2022-11-23Labeling · Supplement 3 · standardAP
2018-10-09UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.